Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
PANHF Quote, Financials, Valuation and Earnings
Last price:
$1.85
Seasonality move
:
-1.3%
Day range:
$1.85 - $1.85
52-week range:
$0.75 - $2.45
Dividend yield:
0%
P/E ratio:
162.28x
P/S ratio:
4.65x
P/B ratio:
6.35x
Volume:
--
Avg. volume:
19
1-year change:
125.55%
Market cap:
$3.9B
Revenue:
$668.1M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PANHF
Ping An Healthcare & Technology Co. Ltd.
|
-- | -- | -- | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -$0.34 | -- | -- | $9.22 |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$138M | -$0.28 | 16.18% | -46.43% | $49.17 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PANHF
Ping An Healthcare & Technology Co. Ltd.
|
$1.85 | -- | $3.9B | 162.28x | $1.25 | 0% | 4.65x |
|
ADAG
Adagene, Inc.
|
$1.85 | $9.22 | $87.2M | -- | $0.00 | 0% | 832.60x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$0.78 | $4.00 | $16.1M | -- | $0.00 | 0% | 0.46x |
|
CPHI
China Pharma Holdings, Inc.
|
$1.31 | -- | $4.3M | -- | $0.00 | 0% | 1.06x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
ZLAB
Zai Lab Ltd.
|
$18.58 | $49.17 | $2.1B | -- | $0.00 | 0% | 4.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PANHF
Ping An Healthcare & Technology Co. Ltd.
|
-- | 2.440 | -- | 1.00x |
|
ADAG
Adagene, Inc.
|
26.49% | 2.508 | -- | 2.23x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | 0.019 | 55.28% | 0.19x |
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.772 | 56.09% | 0.09x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.067 | 12.91% | 11.22x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | 0.005 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PANHF
Ping An Healthcare & Technology Co. Ltd.
|
-- | -- | 0.81% | 0.81% | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -- | -42.07% | -56.44% | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Ping An Healthcare & Technology Co. Ltd. vs. Competitors
-
Which has Higher Returns PANHF or ADAG?
Adagene, Inc. has a net margin of -- compared to Ping An Healthcare & Technology Co. Ltd.'s net margin of --. Ping An Healthcare & Technology Co. Ltd.'s return on equity of 0.81% beat Adagene, Inc.'s return on equity of -56.44%.
Company Gross Margin Earnings Per Share Invested Capital PANHFPing An Healthcare & Technology Co. Ltd.-- -- $490.4M ADAGAdagene, Inc.-- -- $68.7M -
What do Analysts Say About PANHF or ADAG?
Ping An Healthcare & Technology Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Adagene, Inc. has an analysts' consensus of $9.22 which suggests that it could grow by 398.61%. Given that Adagene, Inc. has higher upside potential than Ping An Healthcare & Technology Co. Ltd., analysts believe Adagene, Inc. is more attractive than Ping An Healthcare & Technology Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PANHFPing An Healthcare & Technology Co. Ltd.0 0 0 ADAGAdagene, Inc.6 2 0 -
Is PANHF or ADAG More Risky?
Ping An Healthcare & Technology Co. Ltd. has a beta of 0.230, which suggesting that the stock is 77.041% less volatile than S&P 500. In comparison Adagene, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PANHF or ADAG?
Ping An Healthcare & Technology Co. Ltd. has a quarterly dividend of $1.25 per share corresponding to a yield of 0%. Adagene, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ping An Healthcare & Technology Co. Ltd. pays -- of its earnings as a dividend. Adagene, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PANHF or ADAG?
Ping An Healthcare & Technology Co. Ltd. quarterly revenues are --, which are smaller than Adagene, Inc. quarterly revenues of --. Ping An Healthcare & Technology Co. Ltd.'s net income of -- is lower than Adagene, Inc.'s net income of --. Notably, Ping An Healthcare & Technology Co. Ltd.'s price-to-earnings ratio is 162.28x while Adagene, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ping An Healthcare & Technology Co. Ltd. is 4.65x versus 832.60x for Adagene, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PANHFPing An Healthcare & Technology Co. Ltd.4.65x 162.28x -- -- ADAGAdagene, Inc.832.60x -- -- --
-
Which has Higher Returns PANHF or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -- compared to Ping An Healthcare & Technology Co. Ltd.'s net margin of -353.92%. Ping An Healthcare & Technology Co. Ltd.'s return on equity of 0.81% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital PANHFPing An Healthcare & Technology Co. Ltd.-- -- $490.4M CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About PANHF or CASI?
Ping An Healthcare & Technology Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 431.07%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Ping An Healthcare & Technology Co. Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Ping An Healthcare & Technology Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PANHFPing An Healthcare & Technology Co. Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is PANHF or CASI More Risky?
Ping An Healthcare & Technology Co. Ltd. has a beta of 0.230, which suggesting that the stock is 77.041% less volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.657%.
-
Which is a Better Dividend Stock PANHF or CASI?
Ping An Healthcare & Technology Co. Ltd. has a quarterly dividend of $1.25 per share corresponding to a yield of 0%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ping An Healthcare & Technology Co. Ltd. pays -- of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PANHF or CASI?
Ping An Healthcare & Technology Co. Ltd. quarterly revenues are --, which are smaller than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Ping An Healthcare & Technology Co. Ltd.'s net income of -- is lower than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Ping An Healthcare & Technology Co. Ltd.'s price-to-earnings ratio is 162.28x while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ping An Healthcare & Technology Co. Ltd. is 4.65x versus 0.46x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PANHFPing An Healthcare & Technology Co. Ltd.4.65x 162.28x -- -- CASICASI Pharmaceuticals, Inc.0.46x -- $3.1M -$10.9M
-
Which has Higher Returns PANHF or CPHI?
China Pharma Holdings, Inc. has a net margin of -- compared to Ping An Healthcare & Technology Co. Ltd.'s net margin of -86.16%. Ping An Healthcare & Technology Co. Ltd.'s return on equity of 0.81% beat China Pharma Holdings, Inc.'s return on equity of -43.41%.
Company Gross Margin Earnings Per Share Invested Capital PANHFPing An Healthcare & Technology Co. Ltd.-- -- $490.4M CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M -
What do Analysts Say About PANHF or CPHI?
Ping An Healthcare & Technology Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand China Pharma Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ping An Healthcare & Technology Co. Ltd. has higher upside potential than China Pharma Holdings, Inc., analysts believe Ping An Healthcare & Technology Co. Ltd. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PANHFPing An Healthcare & Technology Co. Ltd.0 0 0 CPHIChina Pharma Holdings, Inc.0 0 0 -
Is PANHF or CPHI More Risky?
Ping An Healthcare & Technology Co. Ltd. has a beta of 0.230, which suggesting that the stock is 77.041% less volatile than S&P 500. In comparison China Pharma Holdings, Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.826%.
-
Which is a Better Dividend Stock PANHF or CPHI?
Ping An Healthcare & Technology Co. Ltd. has a quarterly dividend of $1.25 per share corresponding to a yield of 0%. China Pharma Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ping An Healthcare & Technology Co. Ltd. pays -- of its earnings as a dividend. China Pharma Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PANHF or CPHI?
Ping An Healthcare & Technology Co. Ltd. quarterly revenues are --, which are smaller than China Pharma Holdings, Inc. quarterly revenues of $756.2K. Ping An Healthcare & Technology Co. Ltd.'s net income of -- is lower than China Pharma Holdings, Inc.'s net income of -$651.5K. Notably, Ping An Healthcare & Technology Co. Ltd.'s price-to-earnings ratio is 162.28x while China Pharma Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ping An Healthcare & Technology Co. Ltd. is 4.65x versus 1.06x for China Pharma Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PANHFPing An Healthcare & Technology Co. Ltd.4.65x 162.28x -- -- CPHIChina Pharma Holdings, Inc.1.06x -- $756.2K -$651.5K
-
Which has Higher Returns PANHF or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Ping An Healthcare & Technology Co. Ltd.'s net margin of --. Ping An Healthcare & Technology Co. Ltd.'s return on equity of 0.81% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital PANHFPing An Healthcare & Technology Co. Ltd.-- -- $490.4M SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About PANHF or SVA?
Ping An Healthcare & Technology Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ping An Healthcare & Technology Co. Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Ping An Healthcare & Technology Co. Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PANHFPing An Healthcare & Technology Co. Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is PANHF or SVA More Risky?
Ping An Healthcare & Technology Co. Ltd. has a beta of 0.230, which suggesting that the stock is 77.041% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.723, suggesting its less volatile than the S&P 500 by 27.741%.
-
Which is a Better Dividend Stock PANHF or SVA?
Ping An Healthcare & Technology Co. Ltd. has a quarterly dividend of $1.25 per share corresponding to a yield of 0%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Ping An Healthcare & Technology Co. Ltd. pays -- of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend.
-
Which has Better Financial Ratios PANHF or SVA?
Ping An Healthcare & Technology Co. Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Ping An Healthcare & Technology Co. Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Ping An Healthcare & Technology Co. Ltd.'s price-to-earnings ratio is 162.28x while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ping An Healthcare & Technology Co. Ltd. is 4.65x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PANHFPing An Healthcare & Technology Co. Ltd.4.65x 162.28x -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns PANHF or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Ping An Healthcare & Technology Co. Ltd.'s net margin of -30.98%. Ping An Healthcare & Technology Co. Ltd.'s return on equity of 0.81% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital PANHFPing An Healthcare & Technology Co. Ltd.-- -- $490.4M ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About PANHF or ZLAB?
Ping An Healthcare & Technology Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Zai Lab Ltd. has an analysts' consensus of $49.17 which suggests that it could grow by 164.64%. Given that Zai Lab Ltd. has higher upside potential than Ping An Healthcare & Technology Co. Ltd., analysts believe Zai Lab Ltd. is more attractive than Ping An Healthcare & Technology Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings PANHFPing An Healthcare & Technology Co. Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is PANHF or ZLAB More Risky?
Ping An Healthcare & Technology Co. Ltd. has a beta of 0.230, which suggesting that the stock is 77.041% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.872, suggesting its less volatile than the S&P 500 by 12.778%.
-
Which is a Better Dividend Stock PANHF or ZLAB?
Ping An Healthcare & Technology Co. Ltd. has a quarterly dividend of $1.25 per share corresponding to a yield of 0%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ping An Healthcare & Technology Co. Ltd. pays -- of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PANHF or ZLAB?
Ping An Healthcare & Technology Co. Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Ping An Healthcare & Technology Co. Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$36M. Notably, Ping An Healthcare & Technology Co. Ltd.'s price-to-earnings ratio is 162.28x while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ping An Healthcare & Technology Co. Ltd. is 4.65x versus 4.51x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PANHFPing An Healthcare & Technology Co. Ltd.4.65x 162.28x -- -- ZLABZai Lab Ltd.4.51x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
